Astrana Health (ASTH) Capital Expenditures (2011 - 2026)

Astrana Health has disclosed Capital Expenditures across 16 years of filings, most recently posting $4.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $4.0 million, up 30.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 million (up 2.83% YoY), and the FY2025 annual result was $10.1 million, up 25.84% from the prior year.
• Capital Expenditures came in at $4.0 million for Q1 2026 at Astrana Health, up from $3.1 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $22.9 million in Q4 2022 to a low of -$18.8 million in Q3 2022.
• The 5-year median for Capital Expenditures is $3.1 million (2025), against an average of $4.3 million.
• Peak annual rise in Capital Expenditures reached 17745.92% in 2022, while the deepest fall reached 308.09% in 2022.
• Astrana Health's Capital Expenditures stood at $22.9 million in 2022, then slumped by 69.24% to $7.1 million in 2023, then tumbled by 64.13% to $2.5 million in 2024, then climbed by 21.06% to $3.1 million in 2025, then jumped by 30.55% to $4.0 million in 2026.
• The last three Capital Expenditures figures came in at $4.0 million (Q1 2026), $3.1 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.